Clinical and Healthcare Utilization Outcomes of Parathyroidectomy in CKD and Dialysis Patients.
作者信息
Jones Scott A, Hegerty Katharine, Scuderi Carla, Eglington Jessica, Green Ben, Mallett Andrew
机构信息
Department of Renal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
出版信息
Kidney Int Rep. 2020 May 7;5(7):1086-1089. doi: 10.1016/j.ekir.2020.04.026. eCollection 2020 Jul.
Abstract
摘要
相似文献
1
Clinical and Healthcare Utilization Outcomes of Parathyroidectomy in CKD and Dialysis Patients.慢性肾脏病及透析患者甲状旁腺切除术后的临床及医疗利用结果
Kidney Int Rep. 2020 May 7;5(7):1086-1089. doi: 10.1016/j.ekir.2020.04.026. eCollection 2020 Jul.
2
Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients.继发性甲状旁腺功能亢进对透析前慢性肾脏病患者疾病进展、医疗资源利用和成本的影响。
Curr Med Res Opin. 2008 Nov;24(11):3037-48. doi: 10.1185/03007990802437943. Epub 2008 Oct 2.
3
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD.慢性肾脏病中矿物质代谢紊乱与骨折风险及甲状旁腺切除术需求之间关联的证据的系统评价
Am J Kidney Dis. 2009 Jun;53(6):1002-13. doi: 10.1053/j.ajkd.2009.02.010.
4
CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy.CKD-MBD 管理：甲状旁腺切除术的作用是什么？来自意大利全国性调查的结果。
J Nephrol. 2018 Aug;31(4):585-591. doi: 10.1007/s40620-018-0481-7. Epub 2018 Mar 7.
5
Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.促红细胞生成素对慢性肾脏病患者医疗资源利用、费用及预后的影响
Ann Pharmacother. 2007 Nov;41(11):1761-9. doi: 10.1345/aph.1K194. Epub 2007 Sep 25.
6
Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States.美国医疗保险和商业保险覆盖的非透析依赖型慢性肾病患者中，伴有和不伴有贫血的患者的患病率、治疗模式及医疗资源利用情况
BMC Nephrol. 2018 Mar 15;19(1):67. doi: 10.1186/s12882-018-0861-1.
7
Successful parathyroidectomy guided by intraoperative parathyroid hormone monitoring for primary hyperparathyroidism is preserved in mild and moderate renal insufficiency.在轻度和中度肾功能不全的情况下，术中甲状旁腺激素监测指导的甲状旁腺切除术对于原发性甲状旁腺功能亢进症是有效的。
Surgery. 2018 Mar;163(3):633-637. doi: 10.1016/j.surg.2017.10.047. Epub 2017 Dec 19.
8
Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.继发性甲状旁腺功能亢进的慢性肾脏病患者甲状旁腺切除术后的长期死亡率：一项系统评价和荟萃分析。
Ren Fail. 2016 Aug;38(7):1050-8. doi: 10.1080/0886022X.2016.1184924. Epub 2016 May 19.
9
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).医生对慢性肾脏病-矿物质和骨异常（CKD-MBD）当前评估与治疗的态度调查
Saudi J Kidney Dis Transpl. 2010 Jan;21(1):93-101.
10
Total parathyroidectomy with forearm autotransplantation as the treatment of choice for secondary hyperparathyroidism.甲状旁腺全切除术加前臂自体移植术作为继发性甲状旁腺功能亢进的首选治疗方法。
J Int Med Res. 2011;39(3):978-87. doi: 10.1177/147323001103900333.
本文引用的文献
1
Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis.全国范围内接受血液透析患者甲状旁腺切除术后的临床结局
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):90-7. doi: 10.2215/CJN.03520414. Epub 2014 Dec 16.
2
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.西那卡塞对接受血液透析患者骨折事件的影响：EVOLVE试验
J Am Soc Nephrol. 2015 Jun;26(6):1466-75. doi: 10.1681/ASN.2014040414. Epub 2014 Dec 11.
3
Outcomes after thyroidectomy and parathyroidectomy.甲状腺切除术和甲状旁腺切除术的结果。
Head Neck. 2012 Apr;34(4):477-84. doi: 10.1002/hed.21757. Epub 2011 Jun 2.
4
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).改善全球肾脏病预后组织（KDIGO）慢性肾脏病-矿物质和骨异常（CKD-MBD）诊断、评估、预防及治疗临床实践指南。
Kidney Int Suppl. 2009 Aug(113):S1-130. doi: 10.1038/ki.2009.188.
5
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).不同血清钙、磷和甲状旁腺激素水平的透析患者的死亡风险：透析结局和实践模式研究（DOPPS）
Am J Kidney Dis. 2008 Sep;52(3):519-30. doi: 10.1053/j.ajkd.2008.03.020. Epub 2008 Jun 2.
6
Survival following parathyroidectomy among United States dialysis patients.美国透析患者甲状旁腺切除术后的生存率
Kidney Int. 2004 Nov;66(5):2010-6. doi: 10.1111/j.1523-1755.2004.00972.x.
Zotero 插件